Advice
following a full submission:
ciclosporin 1mg/mL (0.1%) eye drops emulsion (Ikervis®) is accepted for use within NHS Scotland.
Indication under review: treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
Ciclosporin eye drops, compared to vehicle, improved signs of corneal surface damage but not symptoms in patients with severe keratitis associated with dry eye disease.
Download detailed advice188KB (PDF)
Medicine details
- Medicine name:
- ciclosporin (Ikervis)
- SMC ID:
- 1089/15
- Indication:
- treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.
- Pharmaceutical company
- Santen
- BNF chapter
- Eye
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 12 October 2015